FDA approves Abbott's molecular Zika virus test
You are here: Home » News » Industry news » FDA approves Abbott's molecular Zika virus test3 February 2017 • Author: Niamh Marriott, Digital EditorThe US Food and addiction Administration (FDA) has authorised Abbott's molecular test to detect Zika virus in whole blood (when collected alongside a patient-matched serum or plasma sample) for emergency use. "Abbott's molecular test may provide the ability to identify the active virus over a longer time period with whole blood and could provide a more accurate diagnosis. Abbott's Zika research and developmentAbbott has several additional R&D projects underway (currently in development and not yet FDA approved, cleared or authorised) to help address testing needs related to the current Zika outbreak. Today's existing tools to detect Zika and other tropical diseases are laboratory-based and require reliable power sources, but often, testing is needed in remote areas where there are no labs. Through a grant from the US Agency for International Development (USAID), Abbott is exploring the development of a serology test to solve this challenge.collected by :Lucy William
To follow all the new news about
No comments:
Post a Comment